According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
A number of other analysts have also recently weighed in on the company. Lake Street Capital decreased their price objective on Trupanion from $150.00 to $120.00 in a research report on Thursday, February 17th. TheStreet cut shares of Trupanion from a c- rating to a d+ rating in a report on Wednesday, April 6th. Piper Sandler reduced their price objective on shares of Trupanion from $150.00 to $95.00 in a research report on Friday, April 29th. Canaccord Genuity Group lowered their target price on shares of Trupanion from $140.00 to $100.00 in a research report on Friday, April 29th. Finally, Bank of America dropped their price target on shares of Trupanion from $118.00 to $110.00 and set a buy rating for the company in a research report on Wednesday, April 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of Hold and an average target price of $102.60.
Trupanion (NASDAQ:TRUP – Get Rating) last posted its quarterly earnings data on Thursday, April 28th. The financial services provider reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.05). The firm had revenue of $206.00 million for the quarter, compared to the consensus estimate of $202.32 million. Trupanion had a negative return on equity of 8.66% and a negative net margin of 4.26%. The company’s revenue was up 33.2% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.31) EPS. Research analysts predict that Trupanion will post -0.77 EPS for the current fiscal year.
In related news, COO Tricia Plouf sold 3,500 shares of the business’s stock in a transaction dated Thursday, March 17th. The shares were sold at an average price of $85.00, for a total value of $297,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction on Friday, February 4th. The shares were sold at an average price of $90.51, for a total transaction of $362,040.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,958 shares of company stock valued at $2,598,487. 6.77% of the stock is owned by insiders.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Aflac Inc. bought a new position in Trupanion during the first quarter worth about $324,072,000. Norges Bank bought a new position in Trupanion during the fourth quarter worth about $42,575,000. Macquarie Group Ltd. increased its holdings in Trupanion by 277.3% in the 3rd quarter. Macquarie Group Ltd. now owns 275,832 shares of the financial services provider’s stock valued at $21,424,000 after buying an additional 202,729 shares during the period. Capital International Investors grew its holdings in Trupanion by 7.4% during the 4th quarter. Capital International Investors now owns 1,487,447 shares of the financial services provider’s stock worth $196,388,000 after acquiring an additional 102,630 shares during the last quarter. Finally, Tsai Capital Corp bought a new stake in shares of Trupanion in the 3rd quarter valued at $5,968,000. Institutional investors own 83.62% of the company’s stock.
About Trupanion (Get Rating)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
- Get a free copy of the StockNews.com research report on Trupanion (TRUP)
- World Wresting Entertainment Stock is Hulking Up
- High-Yield Weyco Group Returns To Reasonable Levels
- MarketBeat Podcast: Alternative Investing Strategies Despite Market Volatility
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.